Back
Protagonist Therapeutics, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
56
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$87.33
Seasonality Move:
28.35%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiProtagonist Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 65.2% based on the past 9 years of stock performance.
-
Protagonist Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Protagonist Therapeutics, Inc. Stock Undervalued?The current Protagonist Therapeutics, Inc. [PTGX] share price is $86.07. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 65.2% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. Stock Rating
Buy
56
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Is Protagonist Therapeutics, Inc. overpriced?
-
Protagonist Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Protagonist Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
93.25
52-Week Low:
33.70
Prediction Charts
Market Cap:
5.4B
Price in USD:
86.07
Volume:
715.5K
Beta:
1.93
Technical Analysis
SMA50:
77.39
SMA100:
67.13
SMA200:
57.47
52-Wk Change:
108.65%
Stock Predictions
-
Is Protagonist Therapeutics, Inc. stock public?Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
-
What is the Protagonist Therapeutics, Inc. stock quote today?The Protagonist Therapeutics, Inc. stock price is 86.07 USD today.
-
How to buy Protagonist Therapeutics, Inc. stock online?You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 84.84 | 83.24 | 86.02 | 83.17 |
| Nov-14 | 82.18 | 84.61 | 85.90 | 82.06 |
| Nov-17 | 82.79 | 84.77 | 85.45 | 82.79 |
| Nov-18 | 84.77 | 84.39 | 86.36 | 83.79 |
| Nov-19 | 84.54 | 85.13 | 86.64 | 84.45 |
| Nov-20 | 86.36 | 84.20 | 86.95 | 84.00 |
| Nov-21 | 84.24 | 85.40 | 86.67 | 83.64 |
| Nov-24 | 86.59 | 87.69 | 88.34 | 85.71 |
| Nov-25 | 88.46 | 89.86 | 89.88 | 87.76 |
| Nov-26 | 90.00 | 90.07 | 90.85 | 89.50 |
| Nov-28 | 90.00 | 90.00 | 90.46 | 88.78 |
| Dec-1 | 89.61 | 85.64 | 89.85 | 85.00 |
| Dec-2 | 85.75 | 84.65 | 86.39 | 83.52 |
| Dec-3 | 85.43 | 86.07 | 87.10 | 84.73 |
Protagonist Therapeutics, Inc. Earnings
Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics, Inc. Forecast Revenue Growth
Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.43 per share.
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.